P316 Hepatobiliary manifestations measured by vibration-controlled transient elastography in inflammatory bowel disease: A prospective hospital-based cohort study
ECCO'20 Vienna
2020
P317 Key features of bowel ultrasonography in managing inflammatory bowel disease patients
ECCO'20 Vienna
2020
P318 Artificial intelligence of the neural network-assistant for differential diagnosis of IBD
ECCO'20 Vienna
2020
P319 Clinical characteristics of patients with inflammatory bowel disease and metabolic syndrome
ECCO'20 Vienna
2020
P321 Prognosis of intestinal Behcet’s disease according to the Korean consensus-based diagnostic algorithm
ECCO'20 Vienna
2020
P322 Impact of the presence of Epstein–Barr virus in intestinal mucosa of inflammatory bowel disease patients
ECCO'20 Vienna
2020
P324 Deep enteroscopy after balloon dilatation for differential diagnosis of small bowel stricture
ECCO'20 Vienna
2020
P326 Reasons for and effectiveness of switching back to originator infliximab after a prior switch to CT-P13 biosimilar
ECCO'20 Vienna
2020
P327 Effectiveness of anti-TNF vs. vedolizumab as a second biologic in IBD: results from national Swedish registers
ECCO'20 Vienna
2020
P329 ECCO grant recipient: preliminary results of the HOT-TOPIC trial (Hyperbaric Oxygen Therapy for the Treatment Of Perianal fistulas In Crohn’s disease)
ECCO'20 Vienna
2020
P331 Productivity loss in patients with inflammatory bowel disease receiving treatment for iron deficiency anaemia: A comparison of ferric maltol and IV ironECCO'20 Vienna
2020